Search results
Emcure Pharma IPO opens today: GMP rises; should you subscribe to the issue? - CNBC TV18
CNBC TV18· 25 minutes agoThe initial public offering (IPO) of Emcure Pharmaceuticals Ltd. opens for bidding on Wednesday,...
Stay invested, and buy more; there will be more legs to this rally: Varun Saboo
The Economic Times· 1 hour agoVarun Saboo, Head-Equities, Anand Rathi Shares, asks how does one assign a PEG to Nifty? Saboo says...
Emcure Pharma IPO Opens Today: Should You Subscribe? Check Price, GMP, Lot Size, Recommendations -...
News18· 2 hours agoEmcure Pharma IPO: The initial public offering of Emcure Pharmaceuticals Ltd, which is backed by...
Stock market today: Trade setup for Nifty 50 to Bank Nifty, five stocks to buy or sell on Wednesday...
Livemint· 3 hours agoStocks to buy today: Experts have recommended buying these five buy-or-sell stocks — SBI Life,...
Quant Mutual Fund crisis is another lesson in diversification. Here's why - The Economic Times
The Economic Times· 14 hours agoDiversification in the investment world is not limited to spreading your bets across asset classes...
Kill Hollywood Remake Confirmed: Here Are 5 English Films Inspired From Bollywood Iconic Hits
Filmibeat· 15 hours agoDYK Imtiaz Alis Jab We Met inspired Anand Tucker to make Leap Year
Allcargo Gati raises Rs 169.28 cr by issuing equity shares via QIP
Business Standard India· 16 hours agoThe fresh capital secured after fund-raise committee of company's board has approved the issue and...
Vraj Iron and Steel may debut with over 30% gains on July 2
CNBC Awaaz· 17 hours agoVraj Iron and Steel, which manufactures sponge iron, MS billets, and TMT bars under the brand Vraj,...
iQOO to launch Z9 Lite in India on July 15 - CNBC TV18
CNBC TV18· 18 hours agoiQOO is set to launch the iQOO Z9 Lite, an entry-level smartphone, on July 15. It could be a...
Subscribe- Long Term Emcure Pharmaceuticals Ltd; Anand Rathi
CNBC Awaaz· 18 hours agoAnand Rathi, has come out with its report on Emcure Pharmaceuticals Ltd. The research firm has recommended to “ Subscribe- Long Term” the ipo in its research report as on July 02 2024.